Oxogestone
Identifiers | |
---|---|
| |
CAS Number | 3643-00-3 |
PubChem (CID) | 19275 |
ChemSpider | 18186 |
UNII | A98264FU0C |
Chemical and physical data | |
Formula | C20H30O2 |
Molar mass | 302.451 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Oxogestone (INN) is a steroidal progestin related to the 19-norprogesterone derivatives that was synthesized in 1953 and was developed as an injectable hormonal contraceptive in the early 1970s but was never marketed.[1][2][3][4] A 3-phenylpropionate derivative, oxogestone phenpropionate, also exists.[1]
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 919–. ISBN 978-1-4757-2085-3.
- ↑ Farkas M, Szontágh FE (1972). "Clinical experiences concerning the intramuscular contraceptive oxogestone". Acta Eur. Fertil. 3 (1): 37–43. PMID 4679651.
- ↑ Ruíz Velasco V, Alisedo Aparicio LE (1972). "[Side effects of depot contraceptives]". Prensa Med Mex (in Spanish; Castilian). 37 (1): 25–9. PMID 5032612.
- ↑ Bassol, Susana; Garza-Flores, Josue (1994). "Review of ovulation return upon discontinuation of once-a-month injectable contraceptives". Contraception. 49 (5): 441–453. doi:10.1016/0010-7824(94)90003-5. ISSN 0010-7824. PMID 8045131.
This article is issued from Wikipedia - version of the 11/12/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.